WallStSmart

Nutex Health Inc (NUTX)vsUniversal Health Services Inc (UHS)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Universal Health Services Inc generates 1884% more annual revenue ($17.36B vs $875.26M). UHS leads profitability with a 8.6% profit margin vs 8.1%. UHS trades at a lower P/E of 8.1x. UHS earns a higher WallStSmart Score of 76/100 (B+).

NUTX

Buy

55

out of 100

Grade: C-

Growth: 4.7Profit: 9.0Value: 5.7Quality: 5.0

UHS

Strong Buy

76

out of 100

Grade: B+

Growth: 7.3Profit: 7.0Value: 10.0Quality: 7.5
Piotroski: 6/9Altman Z: 2.97
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

NUTXSignificantly Overvalued (-44.5%)

Margin of Safety

-44.5%

Fair Value

$71.26

Current Price

$100.38

$29.12 premium

UndervaluedFair: $71.26Overvalued
UHSUndervalued (+78.6%)

Margin of Safety

+78.6%

Fair Value

$1081.08

Current Price

$186.72

$894.36 discount

UndervaluedFair: $1081.08Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

NUTX4 strengths · Avg: 9.5/10
P/E RatioValuation
9.1x10/10

Attractively priced relative to earnings

Return on EquityProfitability
58.9%10/10

Every $100 of equity generates 59 in profit

Operating MarginProfitability
97.5%10/10

Strong operational efficiency at 97.5%

Price/BookValuation
2.2x8/10

Reasonable price relative to book value

UHS4 strengths · Avg: 8.8/10
P/E RatioValuation
8.1x10/10

Attractively priced relative to earnings

Return on EquityProfitability
21.3%9/10

Every $100 of equity generates 21 in profit

Price/BookValuation
1.6x8/10

Reasonable price relative to book value

EPS GrowthGrowth
42.7%8/10

Earnings expanding 42.7% YoY

Areas to Watch

NUTX3 concerns · Avg: 2.3/10
Market CapQuality
$671.69M3/10

Smaller company, higher risk/reward

Revenue GrowthGrowth
-41.1%2/10

Revenue declined 41.1%

EPS GrowthGrowth
-86.2%2/10

Earnings declined 86.2%

UHS0 concerns · Avg: 0/10

No major concerns identified

Comparative Analysis Report

WallStSmart Research

Bull Case : NUTX

The strongest argument for NUTX centers on P/E Ratio, Return on Equity, Operating Margin.

Bull Case : UHS

The strongest argument for UHS centers on P/E Ratio, Return on Equity, Price/Book. PEG of 1.29 suggests the stock is reasonably priced for its growth.

Bear Case : NUTX

The primary concerns for NUTX are Market Cap, Revenue Growth, EPS Growth.

Bear Case : UHS

No major red flags identified for UHS, but monitor valuation.

Key Dynamics to Monitor

NUTX carries more volatility with a beta of 2.00 — expect wider price swings.

UHS is growing revenue faster at 9.1% — sustainability is the question.

UHS generates stronger free cash flow (293M), providing more financial flexibility.

Monitor MEDICAL CARE FACILITIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

UHS scores higher overall (76/100 vs 55/100). Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Nutex Health Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

Nutex Health, Inc. is a technology-based healthcare services company. The company is headquartered in Houston, Texas.

Universal Health Services Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

UnitedHealth Group Incorporated is an American for-profit multinational managed healthcare and insurance company based in Minnetonka, Minnesota. It offers health care products and insurance services.

Visit Website →

Want to dig deeper into these stocks?